🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

Docon offloads 10% stake in Thyrocare for Rs 668 Cr

EntrackrEntrackr · 4d ago
Docon offloads 10% stake in Thyrocare for Rs 668 Cr
Medial

Docon Technologies Pvt Ltd, a promoter entity of Thyrocare Technologies, has sold 53.33 lakh equity shares representing around 10% of the company’s total paid-up capital through open market transactions on October 24, 2025. The sale was valued at Rs 667.7 crore at an average price of Rs 1,252 per share, according to a stock exchange filing. Following the transaction, Docon’s shareholding in Thyrocare has come down from 71% to 61% and continues to remain a promoter of the diagnostics chain with 3.2 crore shares. The block sale saw strong participation from domestic mutual funds. Among the key buyers were ICICI Prudential Mutual Fund, which purchased 17.49 lakh shares worth Rs 218.9 crore, and Aditya Birla Sun Life Mutual Fund, which picked up 10.33 lakh shares for Rs 129.3 crore. Other prominent investors included HSBC Mutual Fund Midcap Fund (6.66 lakh shares for Rs 83.4 crore), HDFC Mutual Fund (4.44 lakh shares for Rs 55.5 crore), and Eastspring Investments India Consumer Equity Open Limited (3.19 lakh shares for Rs 40 crore). The stake sale comes on the back of leadership transition within the PharmEasy-Thyrocare group. In August 2025, PharmEasy’s co-founder and CEO Siddharth Shah stepped down from his executive role to become the company’s Vice Chairman, while Thyrocare’s chief Rahul Guha was elevated as the new MD and CEO of API Holdings, the parent entity of PharmEasy and Thyrocare. Guha continues to lead Thyrocare alongside his expanded responsibilities at API. Thyrocare recently announced its financial numbers for the second quarter of the ongoing fiscal year FY26, posting a strong performance in the quarter. The company’s revenue from operations grew 22% year-on-year (YoY) to Rs 216.5 crore in Q2 FY26 from Rs 177.36 crore in Q2 FY25. Thyrocare’s profit jumped 81% YoY to Rs 47.9 crore in Q2 FY26, compared to Rs 26.4 crore in the corresponding quarter last year. For the first half of FY26, the company recorded a net profit that grew 71% to Rs 86.1 crore from Rs 50.4 crore in H1 FY25.

EaseMyTrip profit falls 98% in Q1 FY26; spends Rs 370 Cr on 3 acquisitions

EntrackrEntrackr · 2m ago
EaseMyTrip profit falls 98% in Q1 FY26; spends Rs 370 Cr on 3 acquisitions
Medial

EaseMyTrip profit falls 98% in Q1 FY26; spends Rs 370 Cr on 3 acquisitions Online travel aggregator (OTA) platform EaseMyTrip has reported dismal performance during the last quarter, with revenue declining over 25% and profit plunging 98% to Rs 44 lakh. EaseMyTrip’s operating revenue decreased by 25.5% to Rs 114 crore in Q1 FY26 from Rs 25.5 crore in Q1 FY25, as per its financial statements filed with the National Stock Exchange (NSE). Air ticketing contributed 50% of the company’s revenue but fell 47% to Rs 57 crore in Q1 FY26, down from Rs 107 crore in Q1 FY25. Hotel packages accounted for 28.5% of total revenue, generating Rs 32.5 crore. Including other undisclosed income, its total income for Q1 FY26 stood at Rs 120 crore, compared to Rs 156 crore in Q1 FY25. On a quarter-on-quarter basis, EaseMyTrip’s operating revenue fell 18% to Rs 114 crore in Q1 FY26 from Rs 139 crore in Q4 FY25. In line with its scale, total expenses rose 8% to Rs 118 crore in Q1 FY26 from Rs 109 crore in Q1 FY25. Service costs accounted for 15% of the total, falling 5% to Rs 18 crore in Q1 FY26. Payment gateway charges, employee benefits, and advertising were other major costs for EaseMyTrip in the last quarter. EaseMyTrip’s profit after tax (PAT) fell 98.7% to Rs 44 lakh in Q1 FY26 as compared to Rs 34 crore in Q1 FY25. On a unit basis, the Delhi-based company spent Rs 1.04 to earn a rupee of operating revenue with EBITDA of Rs 6.2 crore during the last quarter. In its board meeting, the company also approved an investment of Rs 175 crore in Three Falcons Notting Hill Limited for a 50% stake, the acquisition of 100% stake in AB Finance Private Limited for Rs 194.4 crore, and approved an investment in Vashu Bhagnani Industries Limited. EaseMyTrip closed Thursday's trading session at Rs 9.22, with a 4% increase in its share price. The company’s total market capitalization stood at Rs 3,353 crore (approx $383 million).

Paytm posts Rs 1,918 Cr revenue and Rs 123 Cr profit in Q1 FY26

EntrackrEntrackr · 3m ago
Paytm posts Rs 1,918 Cr revenue and Rs 123 Cr profit in Q1 FY26
Medial

Fintech firm Paytm announced its financial results for the first quarter of the ongoing fiscal year (Q1 FY26) on Tuesday. The Noida-based company reported a revenue of Rs 1,918 crore and a net profit of Rs 123 crore for the period. According to Paytm’s unaudited quarterly report filed with the National Stock Exchange, its revenue from operations increased by 28% year-on-year from Rs 1,501 crore in Q1 FY25 to Rs 1,918 crore in Q1 FY26. Paytm has not disclosed its revenue breakup. The company also added Rs 241 crore from other non-operating sources, bringing its overall revenue to Rs 2,159 crore in Q1 FY26. For the fintech firm, its employee benefits remained the largest cost center, accounting for 32% of the overall cost, which decreased by 33% to Rs 643 crore in Q1 FY26. Its payment processing charges increased by 12% to Rs 581 crore, and marketing expenses decreased by 55% to Rs 100 crore in Q1 FY26. Software, communication, legal, cashback, and other overheads took the total expenditure to Rs 2,016 crore in Q1 FY26 from Rs 2,476 crore in Q1 FY25. Paytm turned profitable and recorded a net profit of Rs 123 crore in Q1 FY26, in contrast to a loss of Rs 840 crore in Q1 FY25. As of July 22, Paytm’s share price rose 3.5% to Rs 1,053 with the total market capitalization standing at Rs 67,218 crore.

FirstCry parent records Rs 1,863 Cr revenue, Rs 75 Cr EBITDA in Q1 FY26

EntrackrEntrackr · 2m ago
FirstCry parent records Rs 1,863 Cr revenue, Rs 75 Cr EBITDA in Q1 FY26
Medial

Brainbees Solutions, the parent of kids-focused omnichannel retailer FirstCry, reported a 13% year-on-year rise in revenue and a 13% reduction in losses for the quarter ending June 2025. FirstCry's revenue from operations grew to Rs 1,862.56 crore in Q1 FY26 from Rs 1,652 crore in Q1 FY25, its unaudited financial statements sourced from the National Stock Exchange (NSE) show. The sale of its products through offline stores and websites in India and the international market was the primary source of revenue, accounting for nearly 77.55% of total operating revenue, while its subsidiary, GlobalBees, contributed Rs 426 crore. The company also made Rs 49 crore from interest income which took its overall revenue to Rs 1,911 crore in Q1 FY26, compared to Rs 1,679 crore in Q1 FY25. For the omnichannel retailer, the cost of procurement of materials accounted for 58% of the overall expenditure which increased 11% year-on-year to Rs 1,145 crore in Q1 FY26 from Rs 1,029 crore in Q1 FY25. FirstCry’s employee benefits stood at Rs 203 crore in Q1 FY26 which includes Rs 60 crore as ESOP cost. The marketing, legal, rent, and technology were other overheads that pushed the overall expenditure to Rs 1,971 crore in Q1 FY26. The decent scale and controlled expenditure helped FirstCry to reduce its losses by 13% to Rs 66.5 crore in Q1 FY26. Notably, the company reported a positive EBITDA of Rs 75 crore. On a unit basis, the company spent Rs 1.06 to earn a Rupee of operating revenue in Q1 FY26. At the end of today’s trading session, FirstCry’s share price stood at Rs 375.35 per share, with a total market capitalization of Rs 19,586 crore (approximately $2.2 billion).

Download the medial app to read full posts, comements and news.